PRM-151 (Zinpentraxin Alfa)
WA42293
Phase 3 small_molecule terminated
Quick answer
PRM-151 (Zinpentraxin Alfa) for Idiopathic Pulmonary Fibrosis is a Phase 3 program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Idiopathic Pulmonary Fibrosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated